29th Pezcoller Symposium
Trento, Italy; June 22-23, 2017
Co-Chairs: David Livingston, Alberto Bardelli, Massimo Loda, Stefano Piccolo
The 2017 Pezcoller Symposium will focus on a growing set of observations in the cancer field and their implications for the future. The past decade has witnessed the development and application of groundbreaking technologies that have improved cancer diagnosis, prognosis making, and therapy. As a result, the outlook for cancer patients has brightened. Chief among these new approaches are a strong and productive thrust towards the discovery and development of powerful targeted agents for cancer therapy; the discovery and of development novel, immunologically-directed therapies that have led to extraordinarily positive therapeutic effects in certain cancer patients; and the growing value of deciphering the sequences of cancer genomes and its contribution to the design of more precise and, hence, effective therapy for individual patients. These major advances, notwithstanding, cure still remains elusive, especially for advanced and particularly aggressive cancers. One major reason is that the basic scientific forces that drive cancer development, establish its aggressive and sometimes lethal nature, and wall it off from immunological killing remain incompletely or poorly understood. Thus, without the growth of new, basic cancer science knowledge, frequent cures of most advanced or aggressive cancers will be difficult to achieve. Hence, this Symposium aims to define the limits of our understanding of the basic biology of cancer cells and of the cells of the tumor microenvironment in which cancers arise and proliferate. It will also propose and describe new opportunities for moving beyond these limits. In essence, this meeting has been built upon the premise that ongoing progress in these endeavors will be needed to achieve ever better cancer therapy and prevention.
Fondazione Alessio Pezcoller
via Dordi, 8 - 38122 Trento (Italy)
Phone +39 0461 980250
Fax +39 0461 980350
Orikata Organizzazione Congressi
Phone +39 0461 824326
Fax +39 0461 824251
Attendance at the meeting will be limited to a maximum of 100 participants, available on first-come first-served basis.
€ 200 (as a contribution to Symposium’s expenses) payable preferably by bank transfer:
Account name: Fondazione Pezcoller, Via Dordi 8 Trento - Italy
Bank name: Unicredit, via Galilei 1 - Trento Italy
Account number/IBAN: IT 26 k 02008 01820 000033200502
Swift Code/BIC: UNCRITM10HV
The registration fee includes: participation to the symposium, congress kit, working lunches, coffee breaks, symposium dinner.
La partecipazione dei ricercatori che operano in Trentino è gratuita grazie al contributo della FONDAZIONE CARITRO.
(bed and breakfast)-Prices are indicative.
• H. Venezia - P.za Duomo € 50/ 72(single/double room)
Ph. +39 0461 234559 - http://www.hotelveneziatn.it/
• AlberMonaco - Via Torre d’Augusto € 63/95 (single/double room)
Ph. +39 0461 983060 - http://www.albermonaco.com/hotel_trento/business_hotel_bed_breakfast
• H. Accademia - Vicolo Colico € 85/128 (single/double room)
Ph. +39 0461 233600 - http://www.accademiahotel.it/
• H. America - Via Torre Verde € 70/106 (single/double room)
Ph. +39 0461 983010 - http://www.hotelamerica.it/
• H. Buonconsiglio - via Romagnosi € 78/98 (single/double room)
Ph. +39 0461 272888 - http://www.hotelbuonconsiglio.com/
• Grand Hotel Trento - P.zza Dante € 99/109(single/double room)
Ph. +39 0461 27100 - http://www.grandhoteltrento.com/
All hotels are at walking distance from the conference hall.
Pezcoller Foundation: The goal of the Foundation is to promote biomedical research in the field of cancer